Long-Term Efficacy of Transoral Mandibular Preservation Therapy for T1-2 SCC of Lateral Oropharynx Confirmed February 3, 2025 What does retrospective data reveal about the 10-year efficacy of transoral mandibular preservation surgery for patients with T1-2 squamous cell carcinoma (SCC) arising from the lateral oropharynx?